5-Bromo-2-Chloro-N-Cyclopentylpyrimidin-4-Amine CAS 733039-20-8 Maʻemaʻe >99.0% (HPLC) Palbociclib Intermediate Factory
ʻO Ruifu Chemical Supply Palbociclib Nā Kūwaena Pili:
Palbociclib CAS 571190-30-2
5-Bromo-2,4-Dichloropyrimidine CAS 36082-50-5
5-Bromo-2-Chloro-N-Cyclopentylpyrimidin-4-Amine CAS 733039-20-8
tert-Butyl 4-(6-Nitropyridin-3-yl)piperazine-1-Carboxylate CAS 571189-16-7
tert-Butyl 4-(6-Amino-3-Pyridyl)piperazine-1-Carboxylate CAS 571188-59-5
6-Bromo-2-Chloro-8-Cyclopentyl-5-Methylpyrido-[2,3-d]pyrimidin-7(8H)-hoʻokahi CAS 1016636-76-2
2-Chloro-8-Cyclopentyl-5-Methyl-8H-Pyrido[2,3-d]pyrimidin-7-one CAS 1013916-37-4
Inoa Kimia | 5-Bromo-2-Chloro-N-Cyclopentylpyrimidin-4-Amine |
Nā huaʻōlelo like | N-(5-Bromo-2-Chloropyrimidin-4-yl)(cyclopentyl)amine;5-Bromo-2-Chloro-4-(Cyclopentylamino)pyrimidine |
Helu CAS | 733039-20-8 |
Helu CAT | RF-PI1851 |
Kūlana Kūʻai | Ma ka waihona, hoʻonui ʻia a hiki i nā tona |
ʻĀpana Molekala | C9H11BrClN3 |
Kaumaha Molecular | 276.56 |
Brand | Kemika Ruifu |
'ikamu | Nā kikoʻī |
Ka nana aku | Keʻokeʻo a hiki i ka pauda keʻokeʻo |
Maʻemaʻe / Kaʻina Hanana | >99.0% (HPLC) |
1 H NMR Spectrum | Kūlike me ka hoʻolālā |
Nalo ma ka maloo | <1.00% |
Huina paumaele | <1.00% |
Kūlana hoʻāʻo | Kūlana ʻoihana |
Hoʻohana | Kūwaena o Palbociclib (CAS: 571190-30-2) |
Pūʻolo: ʻOmole, ʻeke ʻeke Aluminum, 25kg / pahu pahu pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.
Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;E pale i ka malamalama a me ka wai
5-Bromo-2-Chloro-N-Cyclopentylpyrimidin-4-Amine (CAS: 733039-20-8) hiki ke hoʻohana i waena o Palbociclib (CAS: 571190-30-2).Palbociclib (inoa kālepa: Ibrance)he mea hoʻopale koho ia o nā kinases pili cyclin CDK4 a me CDK6.ʻO Palbociclib kahi kinase inhibitor i hōʻike ʻia no ka mālama ʻana i ka hormone receptor (HR) -positive, human epidermal growth factor receptor 2 (HER2) -negative advanced or metastatic breast cancer i hui pū ʻia me: An aromatase inhibitor as initial endocrine based therapy in postmenopausal women;a i ʻole Fulvestrant i nā wahine me ka piʻi ʻana o ka maʻi ma hope o ka endocrine therapy.